The EXPAND study results: Safety and tolerability of siponimod in patients with secondary progressive multiple sclerosis

Authors
Category Primary study
ConferenceEuropean Journal of Neurology
Year 2017
This article has no abstract
Epistemonikos ID: 5f08de4bb886282d8ce17d96f49af005f6009913
First added on: Apr 29, 2026